GlassScriptPhysician profile
Ann R Palmer
NPI 1568541431
$1,429.06
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $914 · 2022: $314 · 2024: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $376.94 | 2021-2022 | |
| Boston Scientific Corporation | $211.55 | 2022-2024 | Wolverine Coronary Cutting Balloon |
| Alnylam Pharmaceuticals INC. | $125.00 | 2021 | |
| Novo Nordisk INC | $123.26 | 2021 | |
| Amgen INC. | $111.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $96.79 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $95.18 | 2024 | Uzedy |
| Astrazeneca Pharmaceuticals LP | $88.89 | 2021-2022 | |
| Shockwave Medical, INC | $79.71 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.42 | 2022 | |
| Merck Sharp & Dohme LLC | $46.46 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.